Roquefort Therapeutics plc (ROQ.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.25M |
| Enterprise Value | 5.31M |
| P/E Ratio | -0.13 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.03 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.2 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -0.19 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -16,000 |
| EBITDA | -1.11M |
| Net Income | -971,803 |
| Diluted EPS | -0.08 |
Balance Sheet
| Total Cash | 182,923 |
| Total Cash/Share | 0.03 |
| Total Debt | 383,650 |
| Total Debt/Equity | 0.08 |
| Current Ratio | 0.63 |
| Book Value Per Share | 0.38 |
Price History
| 52-Week Change | -94.86 |
| 52-Week High | 3 |
| 52-Week Low | 0.9 |
| Moving Average 50 Days | 1.13 |
| Moving Average 200 Days | 1.52 |
Statistics
| Average Volume | 945,472 |
| Shares Outstanding | 16.37M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 27, 2026 |
AD
